RECCHIA, Alessandra
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.663
EU - Europa 4.549
AS - Asia 4.386
SA - Sud America 663
AF - Africa 106
OC - Oceania 54
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.425
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.449
SG - Singapore 1.408
IT - Italia 1.370
GB - Regno Unito 1.159
CN - Cina 1.121
VN - Vietnam 511
SE - Svezia 501
HK - Hong Kong 500
BR - Brasile 499
DE - Germania 353
FR - Francia 216
RU - Federazione Russa 199
FI - Finlandia 168
UA - Ucraina 165
BD - Bangladesh 120
TR - Turchia 113
CA - Canada 102
KR - Corea 100
IN - India 97
ID - Indonesia 81
NL - Olanda 80
JP - Giappone 62
BG - Bulgaria 60
MX - Messico 58
AR - Argentina 54
BE - Belgio 47
IQ - Iraq 47
AU - Australia 44
ZA - Sudafrica 44
AE - Emirati Arabi Uniti 33
IE - Irlanda 32
LT - Lituania 31
BZ - Belize 28
CO - Colombia 24
ES - Italia 24
PK - Pakistan 24
EC - Ecuador 22
MY - Malesia 20
PL - Polonia 20
VE - Venezuela 20
IR - Iran 19
AT - Austria 18
CH - Svizzera 16
CL - Cile 16
CZ - Repubblica Ceca 16
PH - Filippine 16
SA - Arabia Saudita 16
JO - Giordania 15
MA - Marocco 15
UZ - Uzbekistan 12
NP - Nepal 11
NZ - Nuova Zelanda 10
TN - Tunisia 10
PT - Portogallo 9
LU - Lussemburgo 8
RO - Romania 8
SI - Slovenia 8
TH - Thailandia 8
BO - Bolivia 7
DZ - Algeria 7
EG - Egitto 7
KE - Kenya 7
PE - Perù 7
PY - Paraguay 7
RS - Serbia 7
AL - Albania 6
GR - Grecia 6
TW - Taiwan 6
UY - Uruguay 6
AZ - Azerbaigian 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
IL - Israele 5
PS - Palestinian Territory 5
CR - Costa Rica 4
ET - Etiopia 4
KZ - Kazakistan 4
NG - Nigeria 4
OM - Oman 4
PA - Panama 4
QA - Qatar 4
DK - Danimarca 3
EU - Europa 3
GE - Georgia 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
NO - Norvegia 3
TT - Trinidad e Tobago 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CY - Cipro 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
LV - Lettonia 2
MD - Moldavia 2
PR - Porto Rico 2
SV - El Salvador 2
Totale 20.409
Salva come PNG Salva come JPEG
Città #
Fairfield 1.041
Ashburn 1.012
Singapore 962
Santa Clara 892
Southend 746
Chandler 598
Woodbridge 586
Houston 498
Hong Kong 483
San Jose 451
Seattle 382
Cambridge 360
Ann Arbor 336
Wilmington 318
Jacksonville 301
Dearborn 279
Nyköping 274
Hefei 247
Beijing 239
Modena 208
Los Angeles 198
Council Bluffs 190
London 183
Chicago 180
New York 143
Ho Chi Minh City 140
Helsinki 123
Hanoi 118
Bologna 116
San Diego 101
The Dalles 101
Seoul 87
Princeton 73
Buffalo 70
Milan 70
Moscow 64
Jakarta 62
Salt Lake City 62
Sofia 59
Lauterbourg 56
Bremen 55
Eugene 52
Izmir 48
Shanghai 48
Brussels 45
Dallas 41
Elk Grove Village 40
Orem 39
São Paulo 39
Rome 37
Frankfurt am Main 36
Munich 36
Toronto 35
Columbus 32
Da Nang 32
Redwood City 32
Tampa 32
Des Moines 30
Falls Church 30
Belize City 28
Parma 27
Phoenix 27
San Francisco 27
Tokyo 27
Dong Ket 25
Dublin 25
Haiphong 25
Paris 24
Boardman 22
Brooklyn 22
Mexico City 22
Bari 21
Las Vegas 20
Rio de Janeiro 20
Atlanta 18
Baghdad 18
Boston 18
Montreal 18
Mumbai 18
Amsterdam 17
Johannesburg 17
Lancaster 17
Chennai 16
Denver 16
Warsaw 16
Guangzhou 15
Nuremberg 15
Sterling 15
Stockholm 15
Trieste 15
Biên Hòa 14
Poplar 14
Wuhan 14
Albuquerque 13
Fremont 13
Nanjing 13
Naples 13
Portsmouth 13
Ankara 12
Brno 12
Totale 13.905
Salva come PNG Salva come JPEG
Nome #
Closure of a Large Chronic Wound through Transplantation of Gene-Corrected Epidermal Stem Cells 574
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 445
MSC-delivered soluble TRAIl and paclitaxel as novel combinatory treatment for pancreatic adenocarcinoma 421
Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer 421
Inducible Caspase9-mediated suicide gene for MSC-based cancer gene therapy 419
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells 417
IL-7 and IL-15 instruct the generation of human memory stem T cells from naïve precursors 411
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 406
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 405
Transcription factor binding sites are genetic determinants of retroviral integration in the human genome. 400
Targeted Gene Addition in Human Epithelial Stem Cells by Zinc-finger Nuclease-mediated Homologous Recombination 392
Long-term stability and safety of transgenic cultured epidermal stem cells in gene therapy of junctional epidermolysis bullosa. 380
Correction of recessive dystrophic epidermolysis bullosa by transposon-mediated integration of COL7A1 in transplantable patient-derived primary keratinocytes. 368
Transcriptionally regulated and nontoxic delivery of the hyperactive Sleeping Beauty Transposase 367
Transcriptionally regulated and non-toxic delivery of the hyperactive Sleeping Beauty Transposase 362
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 361
Bimodal CD40/Fas-Dependent Crosstalk between iNKT Cells and Tumor-Associated Macrophages Impairs Prostate Cancer Progression 361
Comprehensive genomic access to vector integration in clinical gene therapy 358
Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells 356
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 336
Targeted gene integration in human epidermal stem cells by Zinc-finger nuclease-mediated homologous recombination. 332
Site-specific integration by the adeno-associated virus rep protein 328
Long-Term Skin Regeneration From a Gene-Targeted Human Epidermal Stem Cell Clone 322
Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells 321
A single epidermal stem cell strategy for safe ex vivo gene therapy 320
Development of a Sleeping Beauty transposon-based integration system for gene transfer in human epithelial cells 315
Hot spots of retroviral integrations in human CD34+ hematopoietic cells 312
Design of a regulated lentiviral vector for hematopoietic stem cell gene therapy of globoid cell leukodystrophy 311
Nuclear architecture dictates HIV-1 integration site selection 309
Absence of an intrathecal immune reaction to a helper-dependent adenoviral vector delivered into the cerebrospinal fluid of non-human primates. 304
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion. 298
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 292
Site-specific integration into the human genome: Ready for clinical application? 291
Tracking gene-modified T cells in vivo. 288
AAV-CRISPR Persistence in the Eye of the Beholder 287
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 281
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 277
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 273
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors 272
Collagen VII gene delivery via Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 272
Transcriptional enhancers induce insertional gene deregulation independently from the vector type and design 271
Genotoxic signature in cord blood cells of newborns exposed in utero to a zidovudine-based antiretroviral combination 266
Defining the lentiviral integrome in human hematopoietic cells 264
Non viral gene transfer via Sleeping beauty transposon for Collagen VII delivery in human primary keratinocytes. 253
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 248
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 246
Site-specific integration in mammalian cells mediated by a new hybrid baculovirus-adeno-associated virus vector 237
Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector 237
Relative influence of the adeno-associated virus (AAV) type 2 p5 element for recombinant AAV vector site-specific integration 232
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 232
Differential integrity of TALE nuclease genes following adenoviral and lentiviral vector gene transfer into human cells 231
Beta1 integrin activates Rac1 in Schwann cells to generate radial lamellae during axonal sorting and myelination 229
Gene editing prospects for treating inherited retinal diseases 221
Targeted integration of a large transgene cassette by TALEN and ZFN-mediated homologous recombination. 219
Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy 219
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 212
IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis 210
Transcriptional and epigenetic analyses of the DMD locus reveal novel cisâ acting DNA elements that govern muscle dystrophin expression 203
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 181
Erratum: Genomic analysis of sleeping beauty transposon integration in human somatic cells (PLoS ONE (2014) 9:11 (e112712) DOI: 10.1371/journal.pone.0112712) 180
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 172
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 165
Corrigendum to: “Transcriptional and epigenetic analyses of the DMD locus reveal novel cis-acting DNA elements that govern muscle dystrophin expression”. [Biochim. Biophys. Acta Gene Regul. Mech. 2017 Nov;1860(11):1138–1147.] (Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2017) 1860(11) (1138–1147), (S1874939917301359), (10.1016/j.bbagrm.2017.08.010)) 163
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 160
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 159
Collagen VII gene delivery via an Adeno-Sleeping Beauty transposon in COL7A1-deficient keratinocytes from epidermolysis bullosa patients 157
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 154
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 151
The Journal of Gene Medicine European Society of Gene Therapy Young Investigator Award 2004 144
TALEN-mediated in situ correction of a genetic defect by homologous recombination into the native locus 139
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 135
Engineered nucleases-mediated in situ correction of a genetic defect by homologous recombination into the native locus 135
Restored Collagen VI Microfilaments Network in the Extracellular Matrix of CRISPR-Edited Ullrich Congenital Muscular Dystrophy Fibroblasts 130
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 129
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery–Dreifuss Muscular Dystrophy Fibroblasts 43
Totale 20.692
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.266
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.266
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021114 0 0 0 0 0 0 0 0 0 0 0 114
2021/20221.756 77 173 208 102 113 101 132 123 145 112 279 191
2022/20231.921 211 207 165 218 243 257 50 160 207 25 96 82
2023/20241.186 53 72 93 99 217 70 113 147 28 84 83 127
2024/20253.375 105 42 119 209 650 499 252 250 342 177 336 394
2025/20266.242 403 214 414 726 1.222 423 738 256 668 627 469 82
Totale 20.692